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Exposure to endocrine-active chemicals has
been associated with developmental and
reproductive abnormalities in wildlife and is
suspected to interfere with human endocrine
systems. Screening of endocrine activity has
focused on industrial, pharmaceutical, and
agricultural chemicals. However, recent stud-
ies indicate that endocrine-active chemicals
are also found among preservatives, anti-
oxidants and ultraviolet (UV) ﬁlters that are
constituents of cosmetics. Some UV filters
exhibit estrogenic or antiandrogenic activity
(Holbech et al. 2002; Inui et al. 2003; Ma
et al. 2003; Mueller et al. 2003; Schlumpf
et al. 2001a; Schreurs et al. 2002; Tinwell
et al. 2002). 4-MBC, a UV filter in sun-
screens, and 3-benzylidene camphor, a struc-
turally related UV absorber, are interesting
because they exhibit preference for estrogen
receptor (ER)-β (Schlumpf et al. 2004a). UV
filters also interfere with the mammalian
thyroid axis (Schmutzler et al. 2004).
These compounds represent a new class of
endocrine-active chemicals. The lipophilic,
high-production volume substances with an
increasingly diverse spectrum of use as cos-
metic constituents and technical UV absorbers
are released into the environment and found
in lakes and rivers and in fish (Balmer et al.
2005; Nagtegaal et al. 1997; Poiger et al.
2004). Their main sources are sewage treat-
ment plant (STP) effluents (Plagellat et al.
2006). UV filters in sunscreens may reach
humans and animals via the food web, direct
application of cosmetics (Hayden et al. 1997;
Janjua et al. 2004), and contacts with UV sta-
bilizers in plastics, clothing, curtains, and food
(Kawamura et al. 2003). 
We investigated effects of pre- and postnatal
exposure to 4-MBC in rats. Data on female lit-
termates and brain of both sexes are published
(Durrer et al. 2005; Maerkel et al. 2005,
2007). Here, we report on effects in male off-
spring. The treatment period overlaps with
periods of urogenital tract development during
pre- and early postnatal life that are sensitive to
unbalanced hormonal status. Prostate develop-
ment is testosterone dependent and sensitive to
estrogens (Vom Saal et al. 1997. Woodham
et al. 2003). Perinatal estrogen exposure per-
manently imprints prostate development and
is associated with increased incidence of
prostate hyperplasia, dysplasia, and adenocarci-
noma. The investigation revealed effects on
classic toxicologic end points, expression of
estrogen-regulated genes at mRNA and pro-
tein levels, estrogen sensitivity of target genes,
and nuclear receptor co-repressor levels.
Materials and Methods
Chemicals. 3-(4-methylbenzylidene) camphor
(4-MBC; Eusolex 6300 CAS no. 36861-47-9,
purity 99.7–99.9%) was purchased from Merck
(Dietikon, Switzerland) and 17β-estradiol (E2)
from Calbiochem (Lucerne, Switzerland).
Experimental animals. Long Evans rats
purchased from Møllegaard Breeding and
Research Centre (Ejby, Denmark) were bred
under controlled illumination (lights on
0200–1600 hours) and temperature (22°C ±
1°C) with free access to food and water. The
animal facility is run by the Institute of
Laboratory Animal Sciences, University of
Zurich. Microbiological checks are performed
every 3 months. 
Animal welfare. Animals were treated
humanely and with regard for alleviation of
suffering, in line with the Swiss Law for the
Protection of Animals (Tierschutzgesetz,
9 March 1978) and the Ethical Guidelines
for Animal Experimentation of the Swiss
Academy for Medical Sciences. The project
(no. 132/2003) was approved and regularly
supervised by the Committee for Animal
Experimentation of the State of Zurich and
the Veterinary Ofﬁce of the State of Zurich.
Experimental design. Food pellets contain-
ing 4-MBC. Food pellets with 4-MBC were
prepared by Provimi Kliba AG (Kaiseraugst,
Switzerland). 4-MBC was dissolved in
cold-pressed soy oil (Morga; Ebnat-Kappel,
Switzerland) and added to Provimi Kliba chow
3340 to achieve 4-MBC concentrations of
0.01, 0.1, 0.33, and 0.66 g/kg chow, yielding
an average daily intake of 0.7, 7, 24, or
47 mg/kg/day. Control pellets consisted of the
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BACKGROUND AND OBJECTIVES: In previous studies, we found that the ultraviolet ﬁlter 4-methyl-
benzylidene camphor (4-MBC) exhibits estrogenic activity, is a preferential estrogen receptor
(ER)-β ligand, and interferes with development of female reproductive organs and brain of both
sexes in rats. Here, we report effects on male development.
METHODS: 4-MBC (0.7, 7, 24, 47 mg/kg/day) was administered in chow to the parent generation
before mating, during gestation and lactation, and to offspring until adulthood. mRNA was deter-
mined in prostate lobes by real-time reverse transcription–polymerase chain reaction and protein
was determined by Western blot analysis. 
RESULTS: 4-MBC delayed male puberty, decreased adult prostate weight, and slightly increased
testis weight. Androgen receptor (AR), insulin-like growth factor-1 (IGF-1), ER-α, and ER-β
expression in prostate were altered at mRNA and protein levels, with stronger effects in dorsolateral
than ventral prostate. To assess sensitivity of target genes to estrogens, offspring were castrated on
postnatal day 70, injected with 17β-estradiol (E2; 10 or 50 µg/kg, sc) or vehicle on postnatal
day 84, and sacriﬁced 6 hr later. Acute repression of AR and IGF-1 mRNAs by E2, studied in ven-
tral prostate, was reduced by 4-MBC exposure. This was accompanied by reduced co-repressor
N-CoR (nuclear receptor co-repressor) protein in ventral and dorsolateral prostate, whereas steroid
receptor coactivator-1 (SRC-1) protein levels were unaffected.
CONCLUSIONS: Our data indicate that 4-MBC affects development of male reproductive functions
and organs, with a lowest observed adverse effect level of 0.7 mg/kg. Nuclear receptor coregulators
were revealed as targets for endocrine disruptors, as shown for N-CoR in prostate and SRC-1 in
uterus. This may have widespread effects on gene regulation.
KEY WORDS: androgen receptor, development, estrogen receptors, gene expression, insulin-like
growth factor-1, 4-methylbenzylidene camphor (4-MBC), N-CoR, prostate, puberty, SRC-1, UV
ﬁlter. Environ Health Perspect 115(suppl 1):42–50 (2007). doi:10.1289/ehp.9134 available via
http://dx.doi.org/ [Online 8 June 2007]same matrix (Provimi Kliba 3340) with 1% of
soil oil added. The soy oil preparation (Morga)
was devoid of detectable amounts of phyto-
estrogens (manufacturer’s information). 
4-MBC treatment. We designed the study
to mimic exposure through the food chain. It
followed the design of a two-generation test
without F2. Males and females of the parent
generation (5–6 weeks old) were fed for at least
10 weeks before mating with chow containing
4-MBC (0.01, 0.1, 0.33, and 0.66 g/kg chow)
or with control chow. Treatment continued
throughout pregnancy and lactation and in the
offspring until adulthood. Pregnant dams were
weighed on gestational day (GD)1 (GD1 =
24 hr after onset of mating), GD7, 14, and 22.
Offspring were counted on the day of birth
[postnatal day (PND)1 = GD23), and sexed
and adjusted to 8–10 animals/litter on PND2.
Body weight was recorded on PND2, 4, 6, 9,
12, 13, 14, at puberty onset, and in adulthood.
After weaning (PND28), males and females
were raised separately. Additional parameters
studied include sex ratio, survival rate, righting
reflex, anogenital distance, and eye opening
(Durrer 2004). Onset of puberty (preputial sep-
aration, vaginal opening) was investigated in
males from PND41 and in females from PN30.
Experiment A, control A, together with 7, 24,
and 47 mg/kg 4-MBC, and experiment B, con-
trol B, together with 0.7 mg/kg 4-MBC, were
run separately (Table 1). 
Male offspring used for molecular biologi-
cal analysis of prostate were taken from the
same litters as the females (Durrer et al.
2005). Brain regions of the same male and
female offspring were also analyzed (Maerkel
et al. 2005, 2007). For analysis of male repro-
ductive organ weights and puberty, offspring
from additional litters were included. 
Adult offspring under baseline conditions.
Adult offspring under baseline conditions
were raised without further experimental
manipulation except 4-MBC treatment and
sacriﬁced at 12 weeks by decapitation during
light ether anesthesia. The ventral lobe of
prostate (ventral prostate) and the combined
dorsal + lateral lobes (dorsolateral prostate)
were dissected according to J. Ashby (personal
communication). Dorsal and lateral lobes were
cut inside the borderline with adjacent tissue
to avoid contaminations and achieve identical
preparation times for ventral and dorsal + lat-
eral lobes. Therefore, wet weight was deter-
mined only for ventral lobe. Weights of dorsal
+ lateral and ventral lobes were determined in
13-month-old 4-MBC–exposed offspring in
an additional series (Supplemental material;
http://www.ehponline.org/members/2007/
9134/suppl.pdf). Both tissue pieces were imme-
diately frozen and stored in liquid nitrogen.
Estrogen challenge experiment. Acute respon-
siveness of estrogen target genes was analyzed in
castrated rat offspring. Castration reduces and
stabilizes endogenous androgens and androgen-
derived estrogens. The same protocol was
applied to female offspring (Durrer et al. 2005;
Maerkel et al. 2005, 2007) to compare target
gene responses in both sexes. At 10 weeks, male
offspring were taken out of several litters of
control and 4-MBC–exposed groups (0.01, 0.1,
and 0.33 g/kg chow) and castrated under anes-
thesia 150 µL/100 g body weight sc of an
acqueous solution containing 12.5% Hypnorm
(Janssen-Cilag, Baar, Switzerland), 12.5%
Domitor (Pfizer, Zurich, Switzerland) and
2.5% atropin (Pharmacy of the University
Hospital, Zurich, Switzerland). After 2 weeks
recovery (age 12 weeks), they received an sc
injection of E2 [10 or 50 µg/kg in dimethyl-
sulfoxide (DMSO)] or vehicle (DMSO) (injec-
tion volume 1 µL/g body weight) and were
decapitated 6 hr later. Effects on prostate were
studied in ventral lobe because dissection was
faster and could be better ﬁtted to a strict time
schedule. Animals from the same litters were
studied under baseline conditions.
Quantification of mRNA by real-time
reverse transcription–polymerase chain reaction
(RT-PCR). Real-time RT-PCR was performed
as described previously (Durrer et al. 2005).
Prostate tissues were homogenized in lysis tissue
buffer from RNeasy-mini kit (QIAGEN,
Valencia, CA, USA) by polytron rotor-stator
homogenizer; total RNA isolated according to
manufacturers’s specifications (QIAGEN).
Genomic DNA was digested by DNase-I
(QIAGEN). Quality and concentration of
RNA were determined by measuring absor-
bance at 260 and 280 nm, and RNA integrity
was conﬁrmed by an ethidium bromide-stained
2.5% agarose gel. RNA was stored at –80°C.
For reverse transcription, 10 µg RNA was used
in a total volume of 100 µL containing 1 ×
TaqMan RT buffer (Applied Biosystems,
Rotkreuz, Switzerland), 5.5 mM MgCl2,
500 µM of each deoxynucleoside triphosphate,
2.5 µM random hexamer primers, 0.4 µM
RNase inhibitor, and 1.25 µL MultiScribe
reverse transcriptase (Applied Biosystems). The
mixture was incubated 10 min at 25°C fol-
lowed by 30 min RT at 48°C and 5 min RT
inactivation at 95°C. RT samples were frozen
at –80°C. Primers and probes were designed
using Primer Express 2.0 software (Applied
Biosystems) and were synthesized by
Microsynth (Balgach, Switzerland). Sequences
are summarized in Table 2. RT-PCR cycle
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Table 2. Forward primers (FP), reverse primers (RP), and TaqMan probes with corresponding GenBank
accession number.
Gene (GenBank accession no.)a Primer and probe sequences (5´-3´) 
Androgen receptor (M20133)
FP 5´-CGGAAGGGAAACAGAAGTATCTATG-3´
RP 5´-GGAGACGACACGATGGACAA-3´
Probe 5´-CCAGCAGAAATGATTGCACCATTGATAAATTTC-3´
Estrogen receptor-α (NM_012689)
FP 5´-CCAAAGCCTCGGGAATGG-3´
RP 5´-AGCTGCGGGCGATTGAG-3´
Probe 5´-TCGTTCCCTTGGATCTGGTGCAACAA-3´
Estrogen receptor-β (NM_012754)
FP 5´-TTGGTGTGAAGCAAGATCACTAGAG-3´
RP 5´-AACAGGGCTGGCACAACTG-3´
Probe 5´-CCACTAAGCTTCCTCTTCAGTGTCTCTCTGTTTACA-3´
Insulin-like growth factor-1 (M15481)
FP 5´-GGCCCAGCGCCACA-3´
RP 5´-TGTTTCCTGCACTTCCTCTACTTG-3´
Probe 5´-TGACATGCCCAAGACTCAGAAGGAAGTACA-3´
Cyclophilin (M19533)
FP 5´-TGTGCCAGGGTGGTGACTT-3´
RP 5´-0TCAAATTTCTCTCCGTAGATGGACTT-3´
Probe 5´-CCACCAGTGCCATTATGGCGTGT-3´
aGene names and accession numbers are from GenBank (http://www.ncbi.nlm.nih.gov/).
Table 1. Treatment schedules.
Experimental group Postnatal F1 Adult F1
1. Baseline study
1.1. Untreated control A  Developmental landmarks,  Age 12 weeks:
4-MBC 7, 24, 47 mg/kg/day puberty, no experimental  Organ weights;
1.2. Untreated control B  manipulations mRNA and protein analyses in 
4-MBC 0.7 mg/kg/day ventral and dorsolateral prostate
2. Estrogen challengea
2.1. Untreated control A Postnatal day 70:  Postnatal day 84:
4-MBC 7, 24 mg/kg/day Castration Subcutaneous injection of estradiol
2.2. Untreated control B (10 or 50 µg/kg)b or vehicle;
4-MBC 0.7 mg/kg/day Sacriﬁce after 6 hr;
mRNA in ventral prostate
aOffspring for estrogen challenge experiments (n = 8/group) were taken out of litters from the baseline study. bUntreated
control B and 4-MBC 0.7 mg/kg/day injected only with 10 µg/kg estradiol or vehicle.parameters were an initial denaturating step at
95°C for 10 min, followed by 40 cycles at 95°C
for 15 sec and 60°C for 1 min in ABI PRISM
7700 Sequence Detector (Applied Biosystems).
Sequence Detector Software SDS 2.0
(Applied Biosystems) was used for data analy-
sis. mRNAs were quantitated according to the
standard curve method and normalized to
cyclophilin. Cyclophilin was chosen as refer-
ence because it was found not to be affected by
manipulations of gonadal hormones (Durrer
et al. 2005). mRNA levels of ventral prostates
of intact and castrated rats were compared with
the comparative Ct method. ∆Ct is the differ-
ence of the Ct values of the target gene and of
the reference gene (cyclophilin). The difference
between paired tissue samples (control and
treated) is then obtained as ∆∆Ct = [∆Ct (con-
trol tissue) – ∆Ct (treated tissue)]. For a given
gene, the n-fold differential expression of a test
sample compared with the control was
expressed as 2–∆∆Ct (Applied Biosystems 2001). 
Western blot analysis. Protein levels were
analyzed in the same tissue homogenates
as used for mRNA analysis. Because RNA
stability is most critical, tissue was homoge-
nized in RNA lysis buffer. Protein concentra-
tion was determined by Bradford method
(Bio-Rad Laboratories, München, Germany)
using lyophilized bovine serum albumin
(Fluka, Buchs, Switzerland) as standard. For
acetone precipitation of protein from buffer
RLT lysates, the QIAGEN protocol (http://
www1.qiagen.com/literature/protocols/pdf/
RY22.pdf) was used. After addition of
200 mM dithiothreitol (Fluka), samples
(20 µg protein) were subjected to 10%
sodium dodecyl sulfate–polyacrylamide gel
electrophoresis (SDS-PAGE; Precise Protein
Gels; PIERCE Biotechnology, Inc., Rockford,
IL, USA). The running buffer contained
100 mM Tris base, 100 mM Hepes, 3 mM
SDS. Proteins were transferred onto nitrocel-
lulose membrane (Schleicher & Schuell,
Dassel, Germany) in a Trans-Blot apparatus
(Bio-Rad Laboratories). After transfer, mem-
branes were blocked with 5% non-fat dried
milk in Tris-buffered saline (TBS) containing
0.5% (v/v) Tween 20 (blocking buffer).
Membranes were then incubated overnight
with the first antibody diluted in blocking
buffer. Anti-ER-α and anti-androgen receptor
(AR) (ABR-Affinity BioReagents, Golden,
CO, USA) were diluted 1:5000, ER-β, steroid
receptor coactivator-1 (SRC-1) and anti-
nuclear receptor co-repressor (N-CoR) (Santa
Cruz Biotech, Santa Cruz, CA, USA) 1:2,000,
1:2,500, and 1:1,000 respectively, anti-actin
(Chemicon Int., Temecula, CA, USA)
1:100,000, anti-cyclophilin A (Upstate Cell
Signaling Solutions, Lake Placid, NY, USA)
1:10,000. After three washes with blocking
buffer diluted 1:5 with TBS, membranes were
incubated for 2 hr with the appropriate sec-
ondary antibodies conjugated to horseradish
peroxidase. Proteins were detected using chemi-
luminescence (Pierce). Densitometrical analyses
were performed using AIDA-2D software (Ray-
test, Pittsburgh, PA, USA). Molecular masses
were veriﬁed by using prestained SDS-PAGE
standards [Broad Range (myosin 204 Da to
aprotinin 7 Da)] from Bio-Rad Laboratories.
Binding speciﬁcity of antibodies for the respec-
tive proteins was examined with a negative con-
trol sample. Results are expressed as ratio of the
protein of interest to actin to correct for possi-
ble differences of protein loading between sam-
ples. Values of treated samples were expressed as
percentage of the mean of the control group
loaded on the same blot (control A and 7- or
24-mg/kg group, control B and 0.7-mg/kg
group). Gels run in duplicate for the same two
treatment groups yielded analogous effect pat-
terns. All proteins showed specific signals
(Figure 1)with molecular weights of the
expected size described in the literature and
according to the manufacturer’s instructions. 
Several possible reference proteins were
studied, including β-tubulin used on uterus
(Durrer et al. 2005). Actin was found to be
more appropriate for prostate tissues. The relia-
bility of actin was checked by three approaches:
a) General speciﬁcity checks; with the antibody
used, a clear and consistent protein signal was
obtained (Figure 1). b) Absolute values of actin
did not differ between controls (CON) and 4-
MBC-exposed groups analyzed in the same
blot of dorsolateral prostate  (Table 3). c) Actin
was compared with cyclophilin, which is not
inﬂuenced by estrogen (Durrer et al. 2005), in
the same blot of dorsolateral prostate with sam-
ples from control and treated animals. The
ratio cyclophilin protein/actin protein was the
same in controls and 4-MBC-exposed groups
(Table 3). Thus, actin was equivalent to
cyclophilin in the present setup. The latter
could not be used as reference because its mol-
ecular weight differs considerably from that of
target proteins.
Statistics. Series A (untreated control A,
7, 24, 47 mg/kg 4-MBC) and B (untreated
control B, 0.7 mg/kg 4-MBC) were analyzed
separately because they had been conducted
during different periods. Individual mRNA
Durrer et al.
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Table 3. Analysis of actin as reference protein in dorsolateral prostate (Western blots)
Actin protein density Density ratio
(% of control) a actin protein/cyclophilin proteina
Control 100.0 ± 15.2 (7)
4-MBC 0.7 mg/kg/day 112.6 ± 19.4 (7)
Control 100.0 ± 27.1 (7) 0.79 ± 0.24 (7)
4-MBC 7 mg/kg/day 90.7 ± 17.2 (7) 0.77 ± 0.14 (7)
Control 100.0 ± 10.1 (7) 0.64 ± 0.16 (7)
4-MBC 24 mg/kg/day 97.9 ± 27.9 (7) 0.62 ± 0.12 (7)
aMean ± SD, number of dorsolateral prostate samples. Control and one treatment group were analyzed in one Western
blot. No signiﬁcant group differences in one-way ANOVA.
C 0.7 7 24
N-CoR
SRC-1
AR
ERα
ERβ
Actin
4-MBC (mg/kg/day)
Figure 1. Representative Western blots from dorsolateral prostate of untreated and 4-MBC (0.7, 7, 24
mg/kg/day)-exposed 12-week-old rat offspring. Actin = reference protein. Molecular masses of proteins
veriﬁed by prestained SDS-PAGE standards (Broad Range, Bio-Rad Laboratories).was normalized to cyclophilin mRNA and
expressed as percentage of the respective con-
trol (A, B). Body weight, organ weights, and
mRNA were analyzed by one-way ANOVA
with Bonferroni pair-wise comparisons and
Dunnett’s multiple comparison test for
series A (control A vs. treated groups), and by
Student’s t-test for series B (control B vs.
0.7 mg/kg group). Western-blot gels com-
prised a lane of controls (A or B) and a lane of
samples of one treatment group. Values of
treated samples were expressed as percentage
of the mean of control samples of individual
gels. Differences between control (A or B) and
treated group of individual gels were assessed
by Student’s t-test. Preputial separation and
vaginal opening exhibited positively skewed
distributions also in controls, and were ana-
lyzed with non-parametric Kruskal-Wallis test
followed by Dunn’s multiple comparison test.
(GraphPad Prism 4; GraphPad Software Inc.,
San Diego, CA, USA ). 
Results
Onset of puberty and reproductive organ
weights. 4-MBC was administered to rats in
chow, to the parent generation before mating,
during pregnancy and lactation, and to the
offspring until adulthood (12 weeks)
(Table 1). The treatment delayed puberty
onset in males (preputial separation) at and
above 7 mg/kg (Table 4, not analyzed with
0.7 mg/kg). Two separate experiments started
in summer 2001 and spring 2002 yielded
identical results (Table 4). Body weight
at onset of puberty was at control level in
males, but slightly reduced in females. Adult
body weights of 4-MBC–exposed offspring
were in the control range (Table 5; Durrer
et al. 2005). 
Ventral prostate weight decreased in adult
offspring exposed to 7–47 mg/kg 4-MBC
(Table 5). Investigations in 13-month-old off-
spring showed that 4-MBC reduced both, ven-
tral as well as dorsal + lateral prostate weight
(Appendix). Absolute testis weight was slightly
increased (Table 5). Epididymis and seminal
vesicle weights were unaffected except for rela-
tive epididymis weight at 47 mg/kg. Higher
doses of 4-MBC (24, 47 mg/kg) increased thy-
roid weight (Maerkel et al. 2007). Liver weight
remained unchanged (data not shown).
Effect of pre- and postnatal exposure to
4-MBC on gene expression in prostate lobes of
adult rat offspring. mRNA and protein levels
were determined in the same samples of
ventral prostate and dorsolateral prostate
(dorsal + lateral lobes) in 12-week-old off-
spring under baseline conditions (Table 6;
Figures 1 and 2). AR mRNA and protein
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Table 4. Onset of puberty in male (preputial separation) and female rat offspring (vaginal opening)
4-MBC
Controla 7 mg/kg/day 24 mg/kg/day 47 mg/kg/day
Preputial separation (PND)
Individual animals 45.71 ± 0.82 (52) 46.41 ± 0.84 (41)* 47.55 ± 1.70 (44)# 48.97 ± 2.35 (29)#
Litters 45.95 ± 0.52 (17) 46.35 ± 0.65 (12) 47.82 ± 1.51 (13)# 49.32 ± 1.88 (12)#
Body weight at preputial separation (g) 180.3 ± 10.0 (52) 183.0 ± 11.5 (41) 179.4 ± 10.2 (44) 181.0 ± 11.3 (29)
Vaginal opening (PND)
Individual animals 39.36 ± 2.43 (53) 38.65 ± 2.03 (51) 38.02 ± 1.89 (33) 39.44 ± 1.85 (25)
Body weight at vaginal opening (g) 123.0 ± 10.8 (53) 117.2 ± 9.65 (51)* 112.9 ± 8.60 (33)** 112.2 ± 7.70 (25)**
Combined data are from two series (summer 2001, spring 2002). Means of individual rats for preputial separation series 1/series 2: control 45.76/45.63; 4-MBC: 7 mg/kg/day, 46.89/46.28;
24 mg/kg/day, 47.72/47.42; 47 mg/kg/day, 48.79/49.13.
aData are presented as mean ± SD (number of animals or litters). Different from control: *p < 0.05, **p < 0.01, #p < 0.001.
Table 5. Reproductive organ weights and body weight in 12-week-old male rat offspring after pre- and postnatal exposure to 4-MBC.
Mean individual  Mean individual organ weightsb Mean body weight  Mean organ weights of littersb
Treatmenta body weightb (g) Absolute weight (g) Relative weightc of littersb (g) Absolute weight (g) Relative weightc
Ventral prostate Ventral prostate Ventral prostate Ventral prostate
Untreated control A 351.3 ± 36.7 (34) 0.326 ± 0.068 (34) 0.466 ± 0.093 (34) 354.0 ± 30.8 (13) 0.330 ± 0.060 (13) 0.466 ± 0.077 (13)
4-MBC (7 mg/kg/day) 370.2 ± 23.6 (21) 0.284 ± 0.064 (21)* 0.385 ± 0.088 (21)** 371.4 ± 21.6 (11) 0.296 ± 0.049 (11) 0.398 ± 0.060 (11)*
4-MBC (24 mg/kg/day) 368.8 ± 27.4 (24) 0.283 ± 0.050 (24)*  0.385 ± 0.063 (24)** 371.5 ± 21.6 (11) 0.287 ± 0.042 (11) 0.391 ± 0.053 (11)*
4-MBC (47 mg/kg/day) 352.4 ± 45.0 (23) 0.246 ± 0.057 (23)** 0.349 ± 0.068 (23)# 350.9 ± 39.5 (9) 0.249 ± 0.040 (9)** 0.356 ± 0.045 (9)**
Untreated control B 399.3 ± 21.8 (18) 0.371 ± 0.051 (18) 0.465 ± 0.062 (18) 397.9 ± 14.0 (7) 0.367 ± 0.029 (7) 0.461 ± 0.037 (7)
4-MBC (0.7 mg/kg/day) 399.7 ± 20.3 (15) 0.381 ± 0.062 (15) 0.476 ± 0.065 (15) 400.4 ± 10.0 (6) 0.384 ± 0.041 (6) 0.478 ± 0.044 (6)
Testisd Testis Testisd Testis
Untreated control A 1.462 ± 0.099 (32) 1.683 ± 0.153 (32) 1.453 ± 0.068 (12)  1.656 ± 0.127 (12)
4-MBC (7 mg/kg/day) 1.538 ± 0.064 (21)* 1.719 ± 0.127 (21) 1.551 ± 0.073 (11) 1.675 ± 0.091 (11)
4-MBC (24 mg/kg/day) 1.587 ± 0.117 (24)# 1.725 ± 0.103 (24) 1.597 ± 0.105 (11)** 1.722 ± 0.090 (11)
4-MBC (47 mg/kg/day) 1.594 ± 0.140 (23)# 1.821 ± 0.120 (23)# 1.580 ± 0.137 (9)* 1.813 ± 0.077 (9)**
Untreated control B 1.513 ± 0.050 (18) 1.519 ± 0.091 (18) 1.513 ± 0.032 (7) 1.525 ± 0.058 (7)
4-MBC (0.7 mg/kg/day) 1.481 ± 0.108 (14) 1.481 ± 0.105 (14) 1.498 ± 0.076 (6) 1.486 ± 0.066 (6)
Epididymisd Epididymis Epididymisd Epididymis
Untreated control A 0.440 ± 0.073 (27) 0.637 ± 0.078 (27) 0.444 ± 0.073 (10) 0.635 ± 0.060 (10)
4-MBC (7 mg/kg/day) 0.456 ± 0.097 (20) 0.639 ± 0.121 (20) 0.476 ± 0.088 (9) 0.654 ± 0.122 (9)
4-MBC (24 mg/kg/day) 0.458 ± 0.069 (24) 0.622 ± 0.085 (24) 0.462 ± 0.067 (11) 0.621 ± 0.078 (11)
4-MBC (47 mg/kg/day) 0.396 ± 0.081 (21) 0.566 ± 0.084 (21)* 0.391 ± 0.076 (8) 0.564 ± 0.074 (8)
Untreated control B 0.511 ± 0.055 (11) 0.599 ± 0.107 (11) 0.508 ± 0.052 (4) 0.627 ± 0.039 (4)
4-MBC (0.7 mg/kg/day) 0.495 ± 0.027 (9) 0.617 ± 0.032 (9) 0.500 ± 0.028 (5) 0.618 ± 0.024 (5)
Seminal vesicled Seminal vesicle Seminal vesicled Seminal vesicle
Untreated control A 0.377 ± 0.080 (21) 0.529 ± 0.102 (21) 0.387 ± 0.045 (10) 0.540 ± 0.072 (10)
4-MBC (7 mg/kg/day) 0.407 ± 0.055 (18) 0.550 ± 0.058 (18) 0.406 ± 0.058 (11) 0.550 ± 0.059 (11)
4-MBC (24 mg/kg/day) 0.385 ± 0.065 (23) 0.524 ± 0.085 (23) 0.389 ± 0.052 (10) 0.521 ± 0.068 (10)
4-MBC (47 mg/kg/day) 0.348 ± 0.048 (17) 0.481 ± 0.041 (17) 0.343 ± 0.041 (7) 0.482 ± 0.029 (7)
Untreated control B 0.437 ± 0.039 (9) 0.552 ± 0.047 (9) 0.432 ± 0.042 (5) 0.545 ± 0.038 (5)
4-MBC (0.7 mg/kg/day) 0.437 ± 0.037 (12) 0.552 ± 0.060 (12) 0.444 ± 0.027 (6) 0.562 ± 0.041 (6)
aSeries A: control A and 7, 24, 47 mg/kg/day 4-MBC. Series B: control B and 0.7 mg/kg/day 4-MBC. bData presented are mean ± SD (number of animals or number of litters). cRelative
weights: ventral prostate = absolute (g) /body weight (g) × 500. Testis = absolute (left + right)/body weight × 200. Epididymis and seminal vesicle = absolute (left + right)/body weight
× 250. dTestis, epididymis, seminal vesicle weights = (left + right)/2. Different from control A: *p < 0.05, ** p < 0.01, #p < 0.001.levels were reduced (Figures 2, 3). ER-α
expression was lower in ventral than dorso-
lateral prostate (Table 6; Lau et al. 1998).
4-MBC down-regulated ER-α mRNA in
both tissues. A decrease in ER-α protein was
observed in dorsolateral prostate; in ventral
prostate, the protein was not detectable. ER-β
mRNA was down-regulated in both prostate
parts, but protein was increased in dorsolat-
eral prostate at 7 mg/kg and unchanged in
ventral prostate (Figure 3). The increase in
ER-β protein coincided with the lowest level
of AR protein. Insulin-like growth factor 1
(IGF-1) mRNA was dose dependently down-
regulated. Effects of 4-MBC on all four genes
were greater in dorsolateral prostate.
Acute response to E2 in adult castrated rat
offspring. To examine changes in responsive-
ness of estrogen-regulated genes to E2 in ven-
tral prostate, offspring from different litters of
untreated control groups A and B and 0.7, 7,
and 24 mg/kg/day 4-MBC treatment groups
were castrated at 70 days of age, and after
2 weeks recovery, injected with E2 (10 or
50 µg/kg, sc) 6 hr before sacriﬁce (Table 1).
Effects of castration were analyzed by com-
paring mRNA levels in ventral prostate of
intact adult control offspring with levels in
vehicle-injected castrated control offspring
(comparative Ct method). Castration increased
ER-α, AR, and IGF-1 mRNAs and reduced
ER-β mRNA (Table 7). Transcript levels of
castrated, vehicle-injected groups, which repre-
sent the reference level of E2 challenge experi-
ments, did not differ significantly between
controls and 4-MBC–exposed groups, except
for ER-β mRNA at 0.7 mg/kg (Table 8).
Effect of injection of E2. IGF-1 mRNA
was down-regulated in ventral prostate of cas-
trated controls 6 hr after injection of E2 (10
or 50 µg/kg, sc), relative to the vehicle group
(Figure 4A). An analogous effect of E2 was
observed in 4-MBC–exposed males, except
for one injection group (10 µg/kg E2,
24 mg/kg 4-MBC). However, the magnitude
of the suppressive effect of E2 on IGF-1
mRNA was dose dependently reduced com-
pared with the E2 effect in controls
(Figure 4B). AR mRNA was down-regulated
by both doses of E2 in controls, whereas
4-MBC-exposed animals responded to only
10 µg/kg E2 (Figure 5A). The suppression of
AR mRNA by 50 µg/kg E2 was signiﬁcantly
smaller in 4-MBC–exposed offspring.
ER-α mRNA was down-regulated by E2
(Figure 5B). ER-β mRNA levels were not sig-
niﬁcantly changed by E2 in controls, whereas
a small repressive effect was visible in some
4-MBC–exposed groups (signficant at
24 mg/kg after 10 µg/kg E2. Figure 5C). In
contrast to AR and IGF-1, effects of E2 on
mRNAs encoding for ER-α and ER-β did
not differ significantly between control and
4-MBC–exposed offspring. 
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Figure 2. Levels of mRNAs encoding for insulin-like growth factor-1 (IGF-1), androgen receptor (AR, ER-α , and
ER-β in dorsolateral (A) and ventral (B) prostate of untreated adult (12-week-old) rat offspring and offspring
exposed to 4-MBC; 0.7, 7, 24, 47 mg/kg/day in chow. Real-time RT-PCR values were normalized to cyclophilin
and are expressed as percentage of the mean of the corresponding untreated control (C) [mean ± SE, n = 8,
pooled controls A (n= 8) + B (n= 8)].
Different from corresponding control A (for 7, 24, 47 mg/kg) or B (for 0.7 mg/kg), *p < 0.05, **p < 0.01. Co-regulator protein levels. In 4-MBC–
exposed female littermates, SRC-1 protein
levels were decreased in uterus (Durrer et al.
2005). This was correlated with reduced
inductive effects of E2 on progesterone recep-
tor and IGF-1. SRC-1 protein levels were not
significantly affected in prostate (Figure 6),
but N-CoR protein levels were reduced after
exposure to 0.7, 7 and 24 mg/kg 4-MBC
(Figure 6), to 55.3, 64.5, and 76.1% in dor-
solateral prostate, and 102.4, 85.8, and
75.8% in ventral prostate, respectively.
Discussion
The present study indicates that exposure to
the UV filter 4-MBC throughout ontogeny
until adulthood affects male sexual develop-
ment in rats, puberty, reproductive organ
weights, expression, and estrogen sensitivity
of estrogen-regulated genes in prostate and
N-CoR protein levels. Gene expression is also
altered in uterus of female littermates (Durrer
et al. 2005) and in brain of the same animals
(Maerkel et al. 2005, 2007).
Developmental exposure to estrogenic
substances can delay puberty in male rats
(Biegel et al. 1998; Masutomi et al. 2003),
but data are conflicting [for genistein, see
Masutomi et al. (2003) and Wisniewski et al.
(2003)], and in part negative (Putz et al.
2001b; Takagi et al. 2004). Observations on
hepatic testosterone hydroxylase in prepuber-
tal males indicate that effects of neonatal
estrogen may vary with dose (Putz et al.
2001b). The delay of male puberty by
4-MBC, which binds to ER (Schlumpf et al.
2004a) but not AR (Ma et al. 2003), may be
linked with its estrogenic activity, but it
should be noted that the chemical also inter-
acts with the thyroid axis (Maerkel et al.
2007; Schlumpf et al. 2004b; Schmutzler
et al. 2004). The changes in testis weight
decrease at PN14 (Schlumpf et al. 2001b),
and the slight increase that occurs in adult-
hood may also be linked with estrogenic
activity, as testis weight was reduced on
day 18 after neonatal diethylstilbestrol
(Atanassova et al. 2000) and increased in
adulthood after low-dose neonatal E2 (Putz
et al. 2001b).
Most conspicuous changes were noted in
prostate with a marked decrease in weight as
demonstrated for ventral prostate and in an
additional study also for dorsolateral prostate.
Prostate development appears to be enhanced
by slightly supernormal estrogen levels (Nagel
et al. 1997; Timms et al. 1999; vom Saal et al.
1997) but inhibited by higher estrogen levels
(Prins 1992; Putz et al. 2001a). Activational
responses to androgens are similarly enhanced
or reduced (Naslund and Coffey 1986; Rajfer
and Coffey 1978). Because 4-MBC does not
bind to AR (Ma et al. 2003), the reduction in
prostate weight probably resulted from its
estrogenic activity. The 4-MBC-induced
reduction of AR may also be involved. Effects
of 4-MBC resembled developmental low-dose
actions of estrogen with respect to testis but
high-dose actions with respect to puberty and
prostate weight, suggesting differences in
sensitivity of target systems.
The changes in gene expression in
prostate of adult offspring may have resulted
from effects of 4-MBC during ontogeny,
from ongoing exposure in adulthood or from
a combination of both. mRNAs encoding for
IGF-1, AR, ER-α, and ER-β, and AR and
ER-α proteins were down-regulated in dorso-
lateral and ventral prostate, with statistical
signiﬁcance of changes in mRNA and protein
at the same dose levels. The reduction of
ER-β mRNA is reminiscent of observations
after neonatal estrogen treatment (Prins et al.
1998). Dose–response curves appear to be
monotonic, with the exception of ER-β pro-
tein and possibly N-CoR in dorsolateral
prostate. The increase in ER-β protein at
7 mg/kg, with mRNA at control level, is not
explainable. It might reﬂect combined effects
on receptor synthesis and degradation.
4-MBC exhibits partial agonist features
(Schlumpf et al. 2001a), and partial agonists
can inhibit proteasomal ER degradation (Fan
et al. 2004; Laios et al. 2003), but this should
Pre- and postnatal toxicity of 4-MBC in male rats
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Table 7. mRNA levels in ventral prostate of intact and castrated adult male control offspring.
mRNAa Intact control (%)b Castrated control (%)b
IGF-1 100 ± 13.57 315.19 ± 46.17*
ER-α 100 ± 24.87 2,014.31 ± 520.33*
ER-β 100 ± 15.68 34.51 ± 7.79*
AR 100 ± 6.11 330.62 ± 72.09*
amRNA levels calculated by the comparative Ct method. bPercentage of intact control (mean ± SD , n = 8). *Different from
control, p < 0.05.
Table 8. mRNA levels in adult control and 4-MBC-exposed male rat offspring after castration and vehicle
injection.
Untreated 4-MBC 4-MBC Untreated 4-MBC
mRNA control A  (7 mg/kg/day)a (24 mg/kg/day)a control B (0.7 mg/kg/day)a
IGF-1 100 ± 14.65 85.38 ± 17.81 77.70 ± 13.03 100 ± 9.89 98.56 ± 21.14
ER-α 100 ± 25.83 65.58 ± 16.55 124.82 ± 24.78 100 ± 24.46 97.14 ± 25.87
ER-β 100 ± 22.57 87.25 ± 17.84 82.21 ± 12.10 100 ± 22.64 148.66 ± 28.26*
AR 100 ± 21.80 102.86 ± 16.05 116.19 ± 24.88 100 ± 19.36 106.26 ± 15.18
amRNA as percentage of control A or control B. Mean ± SD, n = 8. *Different from control, p < 0.05.
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Table 6. mRNA levels in prostate lobes of adult control rat offspring.
mRNAa Ventral lobe (VP) (%)b Dorsolateral lobe (DP) (%)b
IGF-1 100 ± 13.57 394.15 ± 68.69*
ER-α 100 ± 24.87 5,512.75 ± 1137.25*
ER-β 100 ± 15.68 114.12 ± 18.20 
AR 100 ± 6.10 70.68 ± 10.49*
amRNA levels calculated by the comparative Ct method. bPercentage of intact VP control (mean ± SD , n = 8). 
*Different from control, p < 0.05.influence also ER-β in ventral prostate and
ER-α levels. 
Lowest AR protein levels coincided with
the ER-β peak in dorsolateral prostate. Mice
lacking ER-β exhibit AR up-regulation in
prostate (Cheng G et al. 2002). Because
4-MBC is a preferential ER-β ligand
(Schlumpf et al. 2004a), actions mediated by
ER-β may have contributed to reduced AR
expression. AR mRNA is also down-regulated
by genistein, considered to be an ER-β ligand
(Fritz et al. 2002). However, expression of AR
probably was affected by additional mecha-
nisms such as impairment of prostate devel-
opment through effects on ER-α. Neonatal
exposure to estrogenic substances can lead to
reduced or enhanced AR expression in adult-
hood (Prins and Birch 1995; vom Saal et al.
1997). The difference has been ascribed
exclusively to dosage, but preference of a lig-
and for ER-α or ER-β might also influence
the effect pattern. Provided they were already
present in early life, the down-regulation of
AR, ER-α and IGF-1 may all have con-
tributed to impaired prostate development.
ER-α has been associated with proliferation
and branching (Asano et al. 2003; Omoto
et al. 2005), IGF-1 also influences prostate
development and appears to be involved in
enhanced branching in response to estrogen
(Gupta 2000; Torring et al. 1997).
Endocrine regulation may be disturbed by
changes in estrogen sensitivity of target genes.
To obtain information on this aspect, the
effect of E2 on gene expression in ventral
prostate was studied in an acute challenge
experiment in littermates of the males studied
under baseline conditions. Endogenous hor-
mone levels were reduced and stabilized by
castration. Castration-induced changes in AR,
ER-α and ER-β and IGF-1 mRNA expres-
sion corresponded to previous observations
(Asano et al. 2003; Bacher et al. 1993;
Nickerson et al. 1999). Acute E2 injection
elicited the expected down-regulation of AR
mRNA, which may be mediated via ER-β
(Weihua et al. 2002). A suppressive effect of
E2 on IGF-1 has previously been observed in
prostate in the absence of testosterone
(Nellemann et al. 2005) and is also indicated
by observations with the antiestrogen ICI
182,780 (Huynh et al. 2001). Exposure to
4-MBC reduced the suppressive effect of E2
on both, AR and IGF-1 mRNA expression,
indicating a reduction of sensitivity of the two
genes to the natural estrogen. In contrast,
down-regulation of ER-α and ER-β by E2
remained unaffected. The direction of change
in estrogen sensitivity induced by 4-MBC was
the same in uterus (Durrer et al. 2005). 
Since ER-β mRNA was not significantly
changed in vehicle-injected castrated animals
by 7 or 24 mg/kg 4-MBC, the reduced
repressive effect of E2 on AR cannot be
ascribed to changes ER-β (Weihua et al.
2002). Sensitivity to steroid hormones also
depends on availability of steroid receptor
coregulators. 4-MBC–induced changes of
coactivator SRC-1 levels in uterus (Durrer
et al. 2005) prompted us to investigate
nuclear receptor coregulator expression in
prostate. In addition to the coactivator SRC-1
(McKenna and O’Malley 2002), the corepres-
sor N-CoR was studied because effects of
hydroxytamoxifen (Lavinsky et al. 1998;
Shang et al. 2000) suggested the possibility of
effects of 4-MBC, which shows partial ER
agonist characteristics (Schlumpf et al. 2001a).
The 4-MBC–induced down-regulation of
N-CoR protein might explain reduced
gene repression by E2, which recruits N-CoR
(Stossi et al. 2006), but N-CoR levels in
castrated rats could not be determined
because the small amount of ventral prostate
homogenate allowed only mRNA analyses.
Reduced baseline AR levels in presence of
reduced sensitivity to E2 and N-CoR levels
indicate that the chronic condition probably
resulted from a combination of multiple
Durrer et al.
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et al. 2001; Woodham et al. 2003).
Our data demonstrate that N-CoR is a
target of endocrine disruptors. N-CoR protein
is reduced by acute administration of E2 in
MCF-7 cells (Frasor et al. 2005) and by
chronic hydroxytamoxifen in a mouse tumor
model (Lavinsky et al. 1998). The effect of E2
was attributed to up-regulation of ubiquitin
ligase and targeting of N-CoR for proteasomal
degradation. Down-regulation of N-CoR may
have implications for gene expression on a
broad scale because N-CoR is recruited by
many transcription factors, it also interacts
with AR (Cheng S et al. 2002; Hodgson et al.
2005). Changes in N-CoR levels may be rele-
vant for prostate ontogeny and adult function. 
In conclusion, our data indicate that pre-
and postnatal exposure of rats to 4-MBC
interferes with male sexual development.
Classical end points showed a lowest observed
adverse effect level (LOAEL) of 7 mg/kg and a
NOAEL of 0.7 mg/kg; molecular end points
(N-CoR) a LOAEL of 0.7 mg/kg. These doses
are 30 and 3 times above an estimated human
exposure level of 0.23 mg/kg (Scientific
Committee on Cosmetic Products and Non-
Food Products 1998). Thus, the margin of
safety (MOS = NOAEL/exposure × 100) may
not be reached. However, we think that risk
considerations should be based on a compari-
son of internal exposure levels in humans and
experimental animals. Adipose tissue levels of
4-MBC in adult rat offspring were 449 ng/g
lipid at 7 mg/kg (Schlumpf et al. 2004b), close
to ﬁsh levels (44–166 ng/g lipid, Balmer et al.
2005). To obtain information on internal
human exposure, a monitoring study on
human milk is presently being conducted. 
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